Drug Shortage Report for ACYCLOVIR SODIUM INJECTION

Last updated on 2021-04-23 History
Report ID 130355
Drug Identification Number 02236916
Brand name ACYCLOVIR SODIUM INJECTION
Common or Proper name Acyclovir Sodium Injection
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ACYCLOVIR
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20mL vial
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-02-05
Estimated end date
Actual end date 2021-04-22
Shortage status Resolved
Updated date 2021-04-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2021-04-23 English Compare
v20 2021-04-22 French Compare
v19 2021-04-22 English Compare
v18 2021-04-13 French Compare
v17 2021-04-13 English Compare
v16 2021-03-24 French Compare
v15 2021-03-24 English Compare
v14 2021-03-03 French Compare
v13 2021-03-03 English Compare
v12 2021-02-16 French Compare
v11 2021-02-16 English Compare
v10 2021-02-06 English Compare
v9 2021-02-05 French Compare
v8 2021-02-05 English Compare
v7 2021-01-26 French Compare
v6 2021-01-26 English Compare
v5 2021-01-18 French Compare
v4 2021-01-18 English Compare
v3 2021-01-16 English Compare
v2 2020-12-17 French Compare

Showing 1 to 20 of 21